Top 10 stocks for today – 24th July, 2023

24 Jul 2023 , 08:45 AM

Here are some stocks that may show significant price movement today.

1. ICICI Bank: During the first quarter, ICICI Bank reported a substantial 40% year-on-year increase in its profit, amounting to Rs 9,648 crore. Additionally, the bank’s net interest income witnessed a robust growth of 38% year-on-year, reaching Rs 18,227 crore.
2. Kotak Bank: Kotak Mahindra Bank posted impressive financial results for the period, with a significant 67% year-on-year increase in its standalone net profit, reaching Rs 3,452 crore. Moreover, the bank’s net interest income also demonstrated strong growth, rising by 33% year-on-year to reach Rs 6,234 crore.
3. Reliance Industries: Reliance Industries recorded an 11% decline in its net profit for the quarter ended in June, resulting in a figure of Rs 16,011 crore. Furthermore, the company’s revenue witnessed a decrease of 5.3% year-on-year, amounting to Rs 2.11 lakh crore.
4. Paytm: The operator of Paytm has shown progress in its financial performance, as it narrowed its net loss for the quarter ended in June FY24 to Rs 357 crore, compared to Rs 644.4 crore in the same period last year. On the revenue front, the company experienced significant growth of 39% year-on-year, reaching Rs 2,342 crore.
5. AU Small Finance: The SFB has achieved impressive financial results for the quarter ended in June FY24, with a substantial 44% year-on-year growth in profit, reaching Rs 387 crore. Additionally, the bank’s pre-provision operating profit also saw a significant increase of 39%, amounting to Rs 546 crore during the same period.
6. Vedanta: The subsidiary of Vedanta Resources reported a consolidated profit of Rs 2,640 crore for the quarter ended in June FY24. However, this figure represents a significant decline of 40% compared to the same period in the previous year.
7. DLF: The real estate major has posted a 12.2% year-on-year growth in its consolidated profit, reaching Rs 528 crore. However, the company’s revenue declined by 1.3% year-on-year, amounting to Rs 1,423.2 crore for the quarter. On a positive note, new sales bookings reached Rs 2,040 crore during the same period, indicating a promising performance in terms of sales.
8. Lupin: The pharmaceutical major has received tentative approval from the United States Food and Drug Administration (US FDA) under the US President’s Emergency Plan for AIDS Relief (PEPFAR) for its new drug application for Dolutegravir Lamivudine and Tenofovir Alafenamide tablets.
9. Aurobindo Pharma: The United States Food and Drug Administration (US FDA) conducted an inspection of the company’s Unit III, a formulation manufacturing facility located in Telangana, from July 14 to July 21. Following the inspection, the US health regulator issued a Form 483 with three observations.
10. Zomato: On July 21, Zomato’s subsidiary, Zomato Media Portugal, Unipessoal Lda (ZM Portugal), began the process of liquidation. However, ZM Portugal is not considered a significant subsidiary of the company.